Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Manchester University NHS Foundation Trust
With
Northern Care Alliance NHS Foundation Trust
This is a prospective longitudinal observational study of patients starting Migalastat as part of routine care. Participants will be recruited from outpatient clinics and have a number of investigations before starting therapy and after twelve months of therapy.
Investigations will include a detailed assessment of symptoms and clinical features, blood tests, echocardiography, detailed cardiac MRI scans, heart rhythm monitoring and exercise capacity assessment.
Parameters will be assessed at baseline and at twelve months.
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Confirmed Fabry disease Aged 16 or over Beginning clinical treatment with Migalastat